Biotech

All Articles

A deeper take a look at Intense Biotech's Intense 15

.In this full week's episode of "The Top Pipe," we are actually diving into Fierce Biotech's yearly ...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's gathering commemorating the approval of Alzheimer's i...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings an...

Lykos will definitely inquire FDA to reevaluate its own selection adhering to turndown of MDMA therapy for trauma

.Following an unsatisfactory revealing for Lykos Therapies' MDMA prospect for post-traumatic stress ...

AN 2 halves census, ceases period 3 test after data let down

.AN2 Therapeutics is reviewing its organization in feedback to lackluster midphase information, vowi...

Merck pays out $700M for bispecific, snooping autoimmune position and chance to challenge Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand beforehand to challenge Amgen in a blood cancer...

Gilead pays out J&ampJ $320M to leave licensing package for seladelpar

.Along With Gilead Sciences almost an FDA choice for its own liver condition medication seladelpar, ...

' All hands on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks can easily find the business putting together outdoors tents at...

Entero giving up team, abandoning office and also pausing R&ampD

.Cushion Liquidators has actually switched Entero Therapeutics white colored as a slab. The lender p...

Exelixis goes down ADC after choosing it is actually no suit for Tivdak

.Exelixis is surrendering on its own tissue element (TF)- targeting antibody-drug conjugate after en...